Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss
· businessinsider.com · popularity 48/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at businessinsider.com →
Summary
Gym bros call it "reta." Eli Lilly is calling it the winner. On Wednesday, the pharmaceutical giant announced the results of the first clinical trial pitting Ozempic against its newest, most powerful, and yet-to-be-approved next-generation injectable medication for obesity and diabetes: …
Found in: Science, Health, Lifestyle. Rating basis: single outlet; outlet tier 4; 3 feeds; listed 3 times; feed position 14.